NVCR

NovoCure
NVCR

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.95B
EV
$1.68B
Shares Outstanding
109.92M
Beta
0.65

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$33.14
P/E 2025E
-
P/Revenue 2025E
3.19x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About NovoCure Limited

gainify
NVCR

NovoCure Limited

NVCR

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The com...

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Danziger, Asaf

Employees

1,488

IPO Date

2015-10-01

Headquarters

No. 4 The Forum, Second Floor, Grenville Street, Saint Helier JE2 4UF, Jersey

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved